Navigation Links
Akorn, Inc. Announces First Quarter 2011 Earnings Release and Conference Call Information
Date:4/8/2011

LAKE FOREST, Ill., April 8, 2011 /PRNewswire/ -- Akorn, Inc. (Nasdaq: AKRX) will host a conference call on Tuesday, May 3, 2011, to discuss first quarter 2011 results followed by a Q&A session.  The company will release earnings the same day before the market opens. Subject:

Akorn First Quarter 2011 Conference CallDate/Time:

Tuesday, May 3, 2011, at 10:00 a.m. Eastern TimeDomestic Callers:

(866) 316-1365International Callers:

(913) 312-0981Confirmation Code:

2538920URL For Webcast:

http://www.videonewswire.com/event.asp?id=78328A live broadcast of Akorn's conference call will also be available online at www.akorn.com under the investor relations tab on May 3, 2011, beginning at 10:00 a.m. (Eastern Time).  The online replay will follow immediately and will be available for 30 days.  

About Akorn, Inc.Akorn, Inc. is a niche pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals.  Akorn has manufacturing facilities located in Decatur, Illinois and Somerset, New Jersey where the Company manufactures ophthalmic and injectable pharmaceuticals.  Additional information is available on the Company's website at www.akorn.com.


'/>"/>

SOURCE Akorn, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. CORRECTED - Akorn, Inc. Announces Date Change for Third Quarter 2010 Earnings Release and Conference Call
2. Akorn, Inc. Announces Third Quarter 2010 Earnings Release and Conference Call Information
3. Hanger Orthopedic Group, Inc. Announces First Quarter 2011 Earnings Release Conference Call
4. Novation Announces the Addition of St. Jude Medical to the Cardiac Rhythm Management Products Portfolio
5. Life Spine® Announces Two New Product Launches at the 2011 American Association of Neurological Surgeons (AANS) Annual Meeting
6. Assured Pharmacy Announces Reverse Stock Split
7. Idenix Pharmaceuticals Announces Proposed Public Offering of Common Stock
8. Ascension Orthopedics Announces TITAN™ Modular Shoulder Implantations at Union Memorial Hospital
9. MEDomics Announces a Growth Capital Investment from SpaGus Ventures LLC and Gary Augusta Joins MEDomics as Chief Operating Officer
10. Shionogi Announces Commercial Availability of CUVPOSA™ (Glycopyrrolate) Oral Solution for Pediatric Chronic Severe Drooling Associated With Neurologic Conditions
11. Mtech Announces Finalists for University of Maryland $75K Business Plan Competition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to create ... it streamlines the reporting process and provides a familiar interface that does not ...
(Date:4/28/2017)... ... ... sleep affects much more than energy – it also has mental and physical benefits. According ... reaction time, which can increase the risk of having a car accident. , This ... NSF to help you sleep better and feel better:, , Turn ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly ... offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and ... These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor and ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... exposed to more adverse experiences than children in the general population. That’s because ... abuse, neglect or other family challenges. While no fault of their own, youth ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection ... improve drug safety and minimize the cost of development. In this webinar, sponsored ... using cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). ...
Breaking Medicine News(10 mins):